SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Completion of transaction with NEX

30 Dec 2016 07:00

RNS Number : 9975S
TP ICAP PLC
30 December 2016
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

Β 

For immediate release

30 December 2016

Β 

TP ICAP plc

Β 

Completion of the acquisition ofNEX's global hybrid voice broking and information business

Β 

TP ICAP plc ("TP ICAP" or the "Company") is delighted to announce that it has completed the acquisition of the global hybrid voice broking and information business of NEX Group plc ("NEX", the new ultimate holding company of the ICAP Group), including NEX's associated technology and broking platforms and certain of NEX's joint ventures and associates ("the Transaction").

At 8:00 a.m. today, 310,314,296 new TP ICAP shares allotted to the shareholders of NEX as consideration in respect of the Transaction will be admitted to the premium listing segment of the Official List of the Financial Conduct Authority ("FCA") and to trading on the London Stock Exchange's main market for listed securities.

Β 

Commenting on today's announcement, John Phizackerley, CEO of TP ICAP, said:

This deal creates the leading interdealer broker in the world. It is a transformational acquisition for TP ICAP, providing a unique opportunity to accelerate our strategy and deliver for our clients, our employees and our shareholders.

Β 

Total Voting Rights

In accordance with Disclosure Guidance and Transparency Rule 5.6.1AR, following the issue of new TP ICAP ordinary shares described above at completion of the Transaction, the total issued share capital of TP ICAP consists of 554,132,671 ordinary shares. TP ICAP does not hold any shares in treasury and the total number of voting rights of TP ICAP is 554,132,671.

The above total voting rights figure 554,132,671 may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in TP ICAP under theΒ FCA's Disclosure Guidance and Transparency Rules.

Β 

Β 

Ends

Β 

Enquiries:

TP ICAP

Alexandra Wick, Marketing & Communications Director

awick@tullettprebon.com

+44 (0) 20 7200 7579

Β 

Rothschild (Financial Adviser and Sponsor to TP ICAP)

Stephen Fox, Toby Ross

+44 (0) 20 7280 5000

Β 

HSBC (Joint Corporate Broker to TP ICAP)

Nick Donald, Peter Glover

+44 (0) 20 7991 8888

Β 

Numis (Joint Corporate Broker to TP ICAP)

Michael Meade, Charles Farquhar

+44 (0) 20 7260 1000

Β 

Brunswick

Kim Fletcher, Eilis Murphy, Craig Breheny

tullettprebon@brunswickgroup.com

+44 (0) 20 7404 5959

Β 

Β 

Important notice

Β 

N M Rothschild & Sons Limited ("Rothschild"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting as the sole sponsor and the sole financial adviser to the Company in connection with the Transaction. Rothschild is acting exclusively for the Company and no-one else in connection with the Transaction and save for any responsibilities and liabilities, if any, which may be imposed on Rothschild, in its capacity as sponsor by the Financial Services and Markets Act 2000, as amended, Rothschild will not be responsible to anyone other than the Company for providing the protections afforded to clients of Rothschild or for providing advice in relation to the Transaction or the contents of this announcement or any transaction, arrangement or matter referred to herein. The information provided in this announcement is entirely based on information provided by the Company and has not been independently verified by Rothschild. Accordingly, Rothschild does not accept any responsibility or liability whatsoever, and makes no representations or warranty, express or implied, for the contents of this announcement. Rothschild disclaims, to the fullest extent permitted by law all and any responsibility and liability howsoever arising which it might otherwise have in respect of this announcement.

Β 

HSBC Bank plc ("HSBC"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, is acting as Joint Corporate Broker to the Company in connection with the Transaction. HSBC is acting exclusively for the Company and no-one else in connection with the Transaction. HSBC will not be responsible to anyone other than the Company for providing the protections afforded to clients of HSBC or for providing advice in relation to the Transaction or the contents of this announcement or any transaction, arrangement or matter referred to herein. The information provided in this announcement is entirely based on information provided by the Company and has not been independently verified by HSBC. Accordingly, HSBC does not accept any responsibility or liability whatsoever, and makes no representations or warranty, express or implied, for the contents of this announcement. HSBC disclaims, to the fullest extent permitted by law all and any responsibility and liability howsoever arising which it might otherwise have in respect of this announcement.

Β 

Numis Securities Limited ("Numis"), which is authorised and regulated by the Financial Conduct Authority, is acting as Joint Corporate Broker to the Company in connection with the Transaction. Numis is acting exclusively for the Company and no-one else in connection with the Transaction. Numis will not be responsible to anyone other than the Company for providing the protections afforded to clients of Numis or for providing advice in relation to the Transaction or the contents of this announcement or any transaction, arrangement or matter referred to herein. The information provided in this announcement is entirely based on information provided by the Company and has not been independently verified by Numis. Accordingly, Numis does not accept any responsibility or liability whatsoever, and makes no representation or warranty, express or implied, for the contents of this announcement. Numis disclaims, to the fullest extent permitted by law all and any responsibility and liability howsoever arising which it might otherwise have in respect of this announcement.

Β 

This announcement has been issued by and is the sole responsibility of TP ICAP.

Β 

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities pursuant to this announcement or otherwise. The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

Β 

This announcement does not constitute an offer of securities for sale in the United States or an offer to acquire or exchange securities in the United States. No offer to acquire securities or to exchange securities for other securities has been made, or will be made, and no offer of securities has been made, or will be made, directly or indirectly, in or into, or by use of the mails, any means or instrumentality of interstate or foreign commerce or any facilities of a national securities exchange of, the United States of America or any other country in which such offer may not be made other than (i) in accordance with the requirements under the US Securities Exchange Act of 1934, as amended, a registration statement under the US Securities Act of 1933, as amended, or the securities laws of such other country, as the case may be, or (ii) pursuant to an available exemption therefrom. No securities are intended to be registered under the US Securities Act of 1933, as amended.

Β 

This announcement has been prepared for the purposes of complying with the applicable law and regulation of the United Kingdom (including the Listing Rules and the Disclosure and Transparency Rules) and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STRQKLFLQLFXFBK
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20262:25 pmRNSDirector/PDMR Shareholding
22nd May 202612:45 pmRNSHolding(s) in Company
13th May 20264:12 pmRNSResult of AGM
13th May 20264:12 pmRNSDirectorate change
13th May 20267:00 amRNSTrading Statement
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20269:00 amRNS2025 Annual Report and Notice of 2026 AGM
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20269:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:05 amRNSLaunch of sixth share buyback programme of £80m
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
5th Nov 20257:00 amRNSTrading Statement
2nd Oct 202510:15 amRNSDirector Declaration
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 202510:30 amRNSHolding(s) in Company
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202510:30 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20255:50 pmRNSHolding(s) in Company
22nd Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.